UK's Largest Independent Chemical Manufacturer Takes Drug Testing In-House With Intelligent Fingerprinting Drug Screening System
Portfolio Pulse from Benzinga Newsdesk
Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced that UK's Robinson Brothers is using its Intelligent Fingerprinting Drug Screening System for in-house drug testing. The system offers a non-invasive, cost-effective, and flexible solution for the 24/7 chemical manufacturing operation, replacing the previous outsourced urine-based testing. The portability and ease-of-use of the system also serve as a deterrent and support the company's Drug and Alcohol Policy.
January 18, 2024 | 1:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Intelligent Bio Solutions Inc.'s drug screening system has been adopted by Robinson Brothers for in-house drug testing, indicating a potential increase in product usage and market penetration.
The adoption of Intelligent Bio Solutions Inc.'s drug screening system by a large independent chemical manufacturer like Robinson Brothers could be seen as a validation of the product's value and effectiveness. This partnership may lead to increased visibility and credibility in the market, potentially resulting in a positive short-term impact on INBS's stock price as investors may anticipate further adoption by other companies.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90